Repository logo
  • English
  • Français
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • Research Outputs
  • Fundings & Projects
  • People
  • Statistics
  • English
  • Français
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Centre for Global Surgery
  3. Dr. Derbew Fikadu Berhe
  4. Anticoagulation quality through time in therapeutic range in Sub-Saharan Africa: a systematic review and meta-analysis
 
  • Details
Options

Anticoagulation quality through time in therapeutic range in Sub-Saharan Africa: a systematic review and meta-analysis

Journal
Frontiers in Medicine
ISSN
2296-858X
Date Issued
2025-03-14
Author(s)
Desalegn Getnet Demsie
Zenaw Debasu Addisu
Chernet Tafere
Kebede Feyisa
Bereket Bahiru
Malede Berihun Yismaw
Getahun Mihret
Abere Tilahun
Desye Gebrie
Derbew Fikadu Berhe
DOI
doi.org/10.3389/fmed.2025.1517162
Abstract
Background: The quality of anticoagulation with warfarin is often assessed through the time in therapeutic range (TTR). However, achieving optimal TTR and maintaining therapeutic INR levels presents significant challenges in Sub-Saharan Africa. This review aims to summarize the existing evidence on the quality of warfarin anticoagulation among patients in Sub-Saharan Africa.

Method: We searched MEDLINE via Ovid, PubMed, Embase via Ovid, and Scopus, and citation analysis from Google Scholar. The review’s primary focus was therapeutic INR and TTR ≥ 65. Meta-analysis was conducted using R version 4.3.3. A mixed-effects meta-regression model was used to examine the influence of moderators, with heterogeneity estimated using I2 and prediction intervals (PI), and publication bias assessed through funnel plots and Egger’s test, with p < 0.05 indicating potential bias. The robustness of pooled proportions was tested using a leave-one-out sensitivity analysis. The preparation of this review adhered to the guidelines outlined in the PRISMA.

Results: We identified 15 observational studies for inclusion in this systematic review and meta-analysis. Egger’s test confirmed an absence of publication bias across these studies. Sensitivity analyses showed consistency in individual therapeutic INR (pooled estimate: 0.37; range: 0.37–0.40) and TTR (pooled estimate: 0.16; range: 0.15–0.17), closely aligning with pooled proportions. Meta-analysis of high-quality TTR measurements yielded a pooled prevalence of 17% (I2 = 89%), with study-specific values ranging from 10 to 29% and predicted effect sizes between 0.05 and 0.34. The therapeutic INR was observed at a pooled prevalence of 40% (I2 = 86%; prediction interval: 0.16, 0.67).

Conclusion: Warfarin therapy is associated with very low percentage of TTR suggests poor quality of anticoagulation management. Sensitivity analyses confirmed the robustness of these findings.
Subjects

warfarin

Sub-Sahara Africa

anticoagulation

INR

TTR

File(s)
No Thumbnail Available
Name

fmed-2-1517162.pdf

Size

1.44 MB

Format

Adobe PDF

Checksum

(MD5):bf82a507d29de1b76c69cde51d7e089e

  • logo.footer.image.logo
  • grid-colum.footer.image.logo
Rwanda:

Office Hours: 8:00 a.m. - 5:00 p.m.
p: 0786.405.072
Kigali Heights, Plot 772
KG 7 Ave., 5th Floor
PO Box 6955
Kigali

United States:

Office Hours: 9:00 a.m. - 5:00 p.m.
800 Boylston Street, Suite 300
Boston, MA 02199

Connect with us:

View our privacy policy.

If you are interested in working for the university, please visit our job board for open positions.

To get in touch with UGHE, please send us an email.

Copyright © 2024, UGHE.org All Rights Reserved

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback